Summary of Purpose
To collect efficacy and safety data on alteplase (rt-PA) in patients aged more than 80 years old, to demonstrate that the treatment of these patients within 3 hours of ischemic stroke onset with rt-PA compared to patients receiving standard treatment, will result in an improved clinical outcome with a favourable benefit/risk ratio.Read More →
The following dates are available for this trial. Trial information last updated on 22 December 2010.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- No-profit study founded by the AIFA - Agenzia Italiana del Farmaco (Italian Medicines Agency, for the Drug approval and vigilance)
National, multicenter, randomized, open label vs standard treatment controlled trial in Italy.